⌘K

Login Start Free

Home/Filings/4/0001415889-24-010901

4//SEC Filing

Haigh Adrian 4

Accession 0001415889-24-010901

CIK 0001211583other

View on SEC.gov Company Profile

Filed

Apr 15, 8:00 PM ET

Accepted

Apr 16, 6:00 PM ET

Size

14.4 KB

Accession

0001415889-24-010901

Insider Transaction Report

Form 4

Period: 2024-04-15

FENNEC PHARMACEUTICALS INC.FENC

Director

Transactions

Exercise/Conversion
Common Shares
2024-04-16$2.31/sh−22,222$51,333→ 449,135 total
Exercise: $2.31From: 2014-04-25Exp: 2024-04-25→ Options (22,222 underlying)
Sale
Common Shares
2024-04-16$2.31/sh+22,222$51,333→ 44,444 total
Sale
Common Shares
2024-04-15$2.31/sh+22,222$51,333→ 22,222 total
Sale
Common Shares
2024-04-16$10.28/sh−22,222$228,389→ 0 total
Sale
Common Shares
2024-04-15$10.30/sh−22,222$228,793→ 22,222 total
Exercise/Conversion
Common Shares
2024-04-15$2.31/sh−22,222$51,333→ 471,357 total
Exercise: $2.31From: 2014-04-25Exp: 2024-04-25→ Options (22,222 underlying)

Footnotes (6)

[F1]Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
[F2]Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
[F3]Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
[F4]Shares acquired pursuant to a 10b5-1 plan dated August 17, 2023.
[F5]Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.
[F6]Option exercise made pursuant to a 10b5-1 plan dated August 17, 2023.

Documents

1 file

4
form4-04162024_100446.xmlPrimary

Issuer

FENNEC PHARMACEUTICALS INC.

CIK 0001211583

Entity typeother

Related Parties

1

filerCIK 0001717425

Filing Metadata

Form type: 4
Filed: Apr 15, 8:00 PM ET
Accepted: Apr 16, 6:00 PM ET
Size: 14.4 KB

View on SEC.gov